10-Q: Energy Fuels Inc. Reports Second Quarter 2024 Results, Advances Rare Earth and Uranium Initiatives

Energy Fuels Inc. reports a net loss for Q2 2024, while making progress in uranium production and rare earth element (REE) initiatives.

Summary

• Energy Fuels Inc. reported a net loss of $6.42 million for the second quarter of 2024, compared to a net loss of $4.89 million in the same period of 2023.
• The company's revenue increased to $8.72 million, up from $6.86 million in Q2 2023, primarily driven by higher uranium sales.
• Uranium concentrate revenue reached $8.59 million, with a realized sales price of $85.90 per pound, compared to $4.34 million and $54.19 per pound in Q2 2023.
• The company sold 100,000 pounds of uranium in Q2 2024, compared to 80,000 pounds in Q2 2023.
• Costs applicable to uranium concentrate revenue were $3.68 million, or $36.81 per pound, compared to $2.34 million, or $29.22 per pound in Q2 2023.
• The company incurred $2.54 million in transaction and integration costs related to the potential acquisition of Base Resources and the Donald Project joint venture.
• The company completed commissioning of its Phase 1 REE separation circuit at the White Mesa Mill and produced approximately 12 tonnes of separated NdPr.
• The company is advancing plans for Phase 2 and Phase 3 REE separation facilities at the Mill.
• The company is also evaluating the potential to recover radioisotopes for use in targeted alpha therapy (TAT) cancer treatments.
• The company is continuing ore production at the Pinyon Plain, La Sal, and Pandora mines, with a target production run rate of 1.1 to 1.4 million pounds of uranium per year once fully ramped up.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While there is positive progress in uranium production and REE initiatives, the company reported a net loss and incurred significant transaction costs. The future outlook is promising, but there are also significant risks and uncertainties.

Positives

• Uranium sales revenue increased significantly due to higher prices and volumes.
• The company successfully commissioned its Phase 1 REE separation circuit.
• The company is making progress on its REE separation capabilities.
• The company is advancing its uranium production at multiple mines.
• The company is exploring new opportunities in medical isotopes.
• The company is actively pursuing strategic acquisitions and joint ventures to secure REE supply.

Negatives

• The company reported a net loss of $6.42 million for Q2 2024.
• The company incurred $2.54 million in transaction and integration costs related to acquisitions and joint ventures.
• The company did not have any RE Carbonate sales in Q2 2024.
• The company did not have any vanadium sales in Q2 2024.
• The company's operating costs remain high.

Risks

• The company's profitability is dependent on the market prices of uranium, vanadium, and REEs.
• The company's REE initiatives are subject to technological and market risks.
• The company's planned acquisitions and joint ventures are subject to regulatory and financial risks.
• The company's operations are subject to environmental and regulatory risks.
• The company's operations are subject to geopolitical risks.
• The company's operations are subject to risks associated with mineral reserve and resource estimates.
• The company's operations are subject to risks associated with estimating mineral extraction and recovery.
• The company's operations are subject to risks associated with commercial production of RE products.
• The company's operations are subject to risks associated with the uranium reserve program for the U.S.
• The company's operations are subject to risks associated with current federal, state and local administrations and changes thereto.
• The company's operations are subject to geological, technical and processing problems.
• The company's operations are subject to risks associated with the depletion of existing mineral resources.
• The company's operations are subject to risks associated with identifying/obtaining adequate quantities of uranium-bearing materials.
• The company's operations are subject to risks associated with labor costs, labor disturbances and unavailability of skilled labor.
• The company's operations are subject to risks associated with availability and/or fluctuations in the costs of raw materials and consumables.
• The company's operations are subject to risks and costs associated with environmental compliance and permitting.
• The company's operations are subject to risks associated with increased regulatory requirements.
• The company's operations are subject to risks associated with our dependence on third parties.
• The company's operations are subject to risks associated with our ability to obtain, extend or renew land tenure.
• The company's operations are subject to risks associated with potential information security incidents.
• The company's operations are subject to risks that we may compromise or lose our proprietary technology or intellectual property.
• The company's operations are subject to risks associated with our ongoing ability to successfully develop, attract and retain qualified management.
• The company's operations are subject to competition for, among other things, capital, mineral properties and skilled personnel.
• The company's operations are subject to the adequacy of, and costs of retaining, our insurance coverage.
• The company's operations are subject to uncertainty as to reclamation and decommissioning liabilities.
• The company's operations are subject to the ability of our bonding companies to require increases in the collateral required to secure reclamation obligations.
• The company's operations are subject to the potential for, and outcome of, litigation and other legal proceedings.
• The company's operations are subject to our ability to meet our obligations to our creditors and to access credit facilities on favorable terms.
• The company's operations are subject to risks associated with our relationships with our business and joint venture partners.
• The company's operations are subject to failure to obtain industry partner, government, and other third-party consents and approvals, when required.
• The company's operations are subject to failure to complete and integrate proposed acquisitions.
• The company's operations are subject to risks associated with the Toliara Project, if acquired by the Company.
• The company's operations are subject to human rights-related risks associated with the conduct of business in foreign countries.
• The company's operations are subject to risks associated with a Brazilian federal or state government enacting or engaging a conservation unit or environmental protection area.
• The company's operations are subject to risks associated with fluctuations in price levels for HMS concentrate (HMC) and its components.
• The company's operations are subject to risks posed by fluctuations in share price levels, exchange rates and interest rates, and general economic conditions.
• The company's operations are subject to risks inherent in our and industry analysts forecasts/predictions of future uranium, vanadium, copper (if and when produced) HMC and REE price levels.
• The company's operations are subject to market prices of uranium, vanadium, REEs, HMC and (if relevant) copper, which are cyclical with substantial price fluctuations.
• The company's operations are subject to risks associated with future uranium sales, if any, being required to be made at spot prices.
• The company's operations are subject to risks associated with our vanadium sales, if any, generally being required to be made at spot prices.
• The company's operations are subject to risks associated with our RE Carbonate sales and REE oxide and other REE product sales, if any, being tied to REE spot prices.
• The company's operations are subject to risks associated with our HMC and its component sales, if any, being tied to ilmenite, rutile, leucoxene and zircon spot prices as well as derived-product titanium and zirconium spot prices.
• The company's operations are subject to failure to obtain suitable uranium sales terms at satisfactory prices in the future.
• The company's operations are subject to failure to obtain suitable vanadium sales terms at satisfactory prices in the future.
• The company's operations are subject to failure to obtain suitable copper (if and when produced), HMC and its components or REE sales terms at satisfactory prices in the future.
• The company's operations are subject to risks that we may not be able to fulfill all our sales commitments out of inventories or production.
• The company's operations are subject to risks associated with any expectation that we will successfully help in the cleanup of historic abandoned uranium mines.
• The company's operations are subject to risks associated with asset impairment as a result of market conditions.
• The company's operations are subject to risks associated with lack of access to markets and the ability to access capital.
• The company's operations are subject to risks associated with our ability to raise debt financing.
• The company's operations are subject to risks associated with public and/or political resistance to nuclear energy or uranium extraction and recovery.
• The company's operations are subject to risks associated with inaccurate or nonobjective media coverage of our activities.
• The company's operations are subject to risks associated with potential impacts of public perceptions on our commercial relations.
• The company's operations are subject to uranium industry competition, international trade restrictions and the impacts they have on world commodity prices of foreign state-subsidized production, and wars or other conflicts influencing international demand and commercial relations.
• The company's operations are subject to risks associated with foreign government actions, policies and laws and foreign state-subsidized enterprises with respect to REE production and sales.
• The company's operations are subject to risks associated with our involvement in industry petitions for trade remedies and the extension of the Russian Suspension Agreement.
• The company's operations are subject to risks associated with governmental or regulatory agency actions, policies, laws, regulations and interpretations with respect to nuclear energy or uranium extraction and recovery, and to HMS, REE and other mineral extraction and recovery activities.
• The company's operations are subject to risks related to potentially higher than expected costs related to any of our projects or facilities.
• The company's operations are subject to risks related to our ability to potentially recover copper from our Pinyon Plain Project, should we decide to pursue it.
• The company's operations are subject to risks related to stock price, volume volatility and market events and our ability to maintain listings in various stock indices.
• The company's operations are subject to risks related to our ability to maintain our listings on the NYSE American and the Toronto Stock Exchange (TSX).
• The company's operations are subject to risks related to dilution of currently outstanding shares from additional share issuances and/or depletion of assets, etc.
• The company's operations are subject to risks related to our securities, including securities regulations, and our lack of dividends.
• The company's operations are subject to risks related to our issuance of additional freely tradeable common shares of the Company (Common Shares) under our At-the-Market program (ATM) or otherwise to provide adequate liquidity in depressed commodity market situations.
• The company's operations are subject to risks related to acquisition and integration issues, or related to defects in title to our mineral properties.
• The company's operations are subject to risks related to our method of accounting for equity investments in other companies potentially resulting in material changes to our financial results that are not fully within our control.
• The company's operations are subject to risks related to conducting business operations in foreign countries including heightened risks of expropriation of assets, business interruption, increased taxation, import/export controls, or unilateral modification of concessions and contracts.
• The company's operations are subject to risks related to any material weaknesses that may be identified in our internal controls over financial reporting.
• The company's operations are subject to risks of amendment to mining laws, including the imposition of any royalties on minerals extracted from federal lands.
• The company's operations are subject to risks related to proposed or completed land exchanges made between federal and state agencies that may impact our unpatented mining claims and other rights.
• The company's operations are subject to risks related to our potential recovery of radioisotopes at the Mill for use in our TAT initiatives.
• The company's operations are subject to risks that we will not successfully complete the acquisition of Base and the Toliara Project or that we will not fully acquire our planned joint venture interest in the Donald Project, or that the Toliara Project and Donald Project will not proceed as planned and be successful.

Future Outlook

The company expects to continue ramping up uranium production, advance its REE initiatives, and evaluate the potential for radioisotope recovery. The company also plans to pursue strategic acquisitions and joint ventures to secure monazite supply and expand its operations.

Management Comments

• The company believes that uranium supply pressure and demand fundamentals point to higher sustained uranium prices in the future.
• The company believes that the advancement of reliable nuclear energy, fueled by uranium, is experiencing a global resurgence.
• The company is seeking additional sources of natural monazite sands to supply feedstock to its emerging REE business.
• The company is evaluating the potential to recover radioisotopes from its existing process streams for use in targeted alpha therapy (TAT) therapeutics for the treatment of cancer.

Industry Context

The report highlights the company's efforts to capitalize on the growing demand for uranium and rare earth elements, driven by the increasing focus on clean energy and advanced technologies. The company's strategic moves, such as the planned acquisition of Base Resources and the joint venture in the Donald Project, reflect the industry's trend towards securing supply chains for critical minerals.

Comparison to Industry Standards

• Energy Fuels' uranium production costs of $36.81 per pound are within the range of other North American producers, but higher than some lower-cost global producers.
• The company's realized uranium price of $85.90 per pound is above the current spot price, reflecting the benefit of long-term contracts.
• The company's REE separation initiatives are in line with the industry's push to diversify supply chains outside of China.
• The company's focus on monazite as a source of REEs is consistent with the industry's trend towards utilizing higher-grade ores.
• The company's efforts to recover radioisotopes for medical applications are innovative and could provide a competitive advantage.
• The company's strategic acquisitions and joint ventures are similar to other companies in the sector seeking to secure access to critical mineral resources.

Legal Proceedings

• The Ute Mountain Ute Tribe has filed administrative appeals and petitions challenging the State of Utah's approvals related to the White Mesa Mill. The company does not consider these actions to have any merit.

Related Party Transactions

• Robert W. Kirkwood, a member of the company's Board of Directors, is a principal of the Kirkwood Companies, including United Nuclear LLC, which owns a 19% interest in the company's Arkose Mining Venture.
• The company provided services to Consolidated Uranium Inc. (CUR) under a mine operating agreement, earning $0.04 million during the six months ended June 30, 2024.

Stakeholder Impact

• Shareholders may be concerned about the net loss reported for Q2 2024, but encouraged by the progress in uranium production and REE initiatives.
• Employees may be impacted by the company's growth and expansion plans, as well as any changes in operations.
• Customers may benefit from the company's increased uranium production and REE supply.
• Suppliers may see increased demand for their products and services as the company expands its operations.
• Creditors may be impacted by the company's financial performance and any changes in its debt levels.

Next Steps

• The company plans to continue ramping up uranium production at its Pinyon Plain, La Sal, and Pandora mines.
• The company plans to advance permitting and development on its Roca Honda, Sheep Mountain, and Bullfrog projects.
• The company plans to continue development of its Phase 2 and Phase 3 REE separation facilities at the White Mesa Mill.
• The company plans to continue evaluating the potential to recover radioisotopes for use in targeted alpha therapy (TAT) cancer treatments.
• The company plans to pursue the acquisition of Base Resources and the joint venture in the Donald Project.
• The company plans to continue to evaluate additional spot and/or long-term uranium sales opportunities.

Key Dates

Keywords

uranium, rare earth elements, REE, monazite, White Mesa Mill, mining, nuclear energy, vanadium, heavy mineral sands, HMS, NdPr, targeted alpha therapy, TAT, radioisotopes